IMMUNICUM AB has a total of 51 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are DIABCELL PTY LTD, PALESE PETER and SEMENTIS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | China | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | United States | 6 | |
#5 | Republic of Korea | 5 | |
#6 | Brazil | 4 | |
#7 | Hungary | 4 | |
#8 | Australia | 2 | |
#9 | Canada | 2 | |
#10 | Slovenia | 2 | |
#11 | Hong Kong | 1 | |
#12 | Japan | 1 | |
#13 | Mexico | 1 | |
#14 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Andersson Bengt | 40 |
#2 | Karlsson-Parra Alex | 39 |
#3 | Wallgren Anna-Carin | 13 |
#4 | Wallgren Annacarin | 8 |
#5 | Alex Karlsson-Parra | 6 |
#6 | Karlsson Parra Alex | 5 |
#7 | Bengt Andersson | 5 |
#8 | Wallgren Anna Carin | 4 |
#9 | Anna-Carin Wallgren | 2 |
#10 | Wallgren Anna C | 1 |
Publication | Filing date | Title |
---|---|---|
HUE047540T2 | Improved allogeneic dendritic cells for use in cancer treatment | |
CN110042081A | Being divided into of monocyte from allogeneic donor | |
HK1168869A1 | Method for proliferation of antigen-specific cells | |
EP2696894A2 | Method for priming of t cells | |
CN103502439A | Method for proliferation of antigen-specific T cells | |
BR112012019267A2 | pro-inflammatory dendritic cell (dc) comprising mature pro-inflammatory dendritic cell (dc), method for producing mature pro-inflammatory dendritic cell (dc) | |
HUE028352T2 | Improved composition for inhibiting tumor cell proliferation | |
CN102597222A | Method for proliferation of antigen-specific T cells | |
US2005158328A1 | Method and composition for producing a cellular allogeneic vaccine | |
SE0201726D0 | Producing cellular allogeneic vaccine based upon allogeneic antigen presenting cells, by modifying isolated antigen presenting cells with antigen, treating antigen presenting cells with agent |